Drug intelligence / Profile preview

n-acetylcysteine + simethicone

Development stage
Unknown
Lead developer
Sanjay Gandhi Postgraduate Institute of Medical Sciences
Modality
Small Molecules
Administration
Oral
01

Overview

This combination is a pre-procedure oral solution consisting of the mucolytic agent N-acetylcysteine and the anti-foaming agent simethicone. It is being investigated by the Sanjay Gandhi Postgraduate Institute of Medical Sciences for its ability to enhance mucosal visibility during upper gastrointestinal endoscopy. N-acetylcysteine works by reducing the viscosity of mucus through the cleavage of disulfide bonds in mucoproteins, while simethicone acts physically to reduce the surface tension of gas bubbles, causing them to coalesce and disperse. By clearing mucus and foam, the combination improves the diagnostic yield for gastric lesions, including early-stage cancers, ulcers, and erosions, which might otherwise be obscured during the procedure.

Brand names
ACC 200 NEOACC200 NEOACC-200 NEO
Other names
N-acetylcysteine and simethicone combination drinkNAC + simethicone
02

Targets

Gas-liquid interfaces of gastrointestinal foam bubbles

Beyond the preview

Go deeper on n-acetylcysteine + simethicone.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on n-acetylcysteine + simethicone.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call